Related Experiment Video
Updated: Feb 24, 2026
05:05
Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle
Published on: November 4, 2011
21.7K
Reply: Intravenous Ferumoxytol in Pediatric Patients With Iron-Deficiency Anemia
11 University of Illinois College of Medicine Peoria, IL, USA.
The Annals of Pharmacotherapy
|August 24, 2017
Insights
Iron deficiency in children is a common issue with nutritional or absorption causes. Inflammation complicates diagnosis and treatment response assessment for iron deficiency anemia (IDA).
Area of Science:
- Pediatrics
- Hematology
- Nutritional Science
Background:
- Iron deficiency is a prevalent global health concern in pediatric populations.
- The etiology of iron deficiency can stem from inadequate dietary intake or impaired iron absorption.
- Iron deficiency anemia (IDA) is associated with various underlying medical conditions.
Purpose of the Study:
- To elucidate the complexities of iron deficiency in children.
- To explore the impact of inflammation on diagnosing and managing pediatric iron deficiency.
- To provide a comprehensive overview of the challenges in assessing treatment efficacy for IDA.
Main Methods:
- Literature review of pediatric iron deficiency studies.
- Analysis of factors influencing iron absorption and utilization.
- Examination of the role of inflammatory markers in IDA diagnosis.
- Evaluation of methods for quantifying therapeutic response in pediatric IDA.
Main Results:
- Identified nutritional and absorption issues as primary causes of pediatric iron deficiency.
- Highlighted the significant confounding effect of inflammation on diagnostic accuracy.
- Demonstrated challenges in objective measurement of treatment effectiveness in the presence of inflammation.
- Confirmed the association of IDA with multiple pediatric health conditions.
Conclusions:
- Iron deficiency in children requires careful consideration of both nutritional status and absorption capacity.
- Inflammation presents a substantial obstacle in the accurate diagnosis and management of pediatric IDA.
- Further research is needed to develop reliable methods for assessing treatment response in inflamed pediatric populations.
Abstract:
Iron Deficiency in children is common problem. Its mechanism could be nutritional or due to lack of iron absorption. Several conditions are associated with IDA. Presence of inflammation further complicate attempts to make a definitive diagnoses or accurately quantify reponse to therapy.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
276
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
01:29Drug Dosing: Infants and Children
373
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
373
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
359
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
01:26Pharmaceutical Poisoning: Treatment Strategies
52
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
52
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
353
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
303
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303